Cargando…
[(223)Ra] RaCl(2) nanomicelles showed potent effect against osteosarcoma: targeted alpha therapy in the nanotechnology era
The treatment of bone metastatsis as primary bone cancer itself is still a challenge. The use od radium dichloride ([(223)Ra] RaCl(2)) has emerged in the last few years as one of the best treatment choice for bone cancer, with especial focus in bone metastasis. The alpha-emitter radiopharmaceutical...
Autores principales: | Yang, Yang, Alencar, Luciana Magalhães Rebelo, Pijeira, Martha Sahylí Ortega, Batista, Beatriz da Silva, França, Alefe Roger Silva, Rates, Erick Rafael Dias, Lima, Ruana Cardoso, Gemini-Piperni, Sara, Santos-Oliveira, Ralph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741223/ https://www.ncbi.nlm.nih.gov/pubmed/35191342 http://dx.doi.org/10.1080/10717544.2021.2005719 |
Ejemplares similares
-
Nanomicelles of Radium Dichloride [(223)Ra]RaCl(2) Co-Loaded with Radioactive Gold [(198)Au]Au Nanoparticles for Targeted Alpha–Beta Radionuclide Therapy of Osteosarcoma
por: Souza, Bárbara Nayane Rosário Fernandes, et al.
Publicado: (2022) -
Ultrastructural Analysis of Cancer Cells Treated with the Radiopharmaceutical Radium Dichloride ([(223)Ra]RaCl(2)): Understanding the Effect on Cell Structure
por: Diniz Filho, Joel Félix Silva, et al.
Publicado: (2023) -
Comparing absorbed doses and radiation risk of the α-emitting bone-seekers [(223)Ra]RaCl(2) and [(224)Ra]RaCl(2)
por: Lassmann, Michael, et al.
Publicado: (2023) -
Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [(223)Ra]RaCl(2) therapy
por: Sraieb, Miriam, et al.
Publicado: (2020) -
α-Particle-induced DNA damage tracks in peripheral blood mononuclear cells of [(223)Ra]RaCl(2)-treated prostate cancer patients
por: Schumann, S., et al.
Publicado: (2021)